Abstract: The present disclosure is related to packages for disposable wipes. The packages comprise a dispensing fitment formed of a first polymer composition comprising polyethylene and a flexible package body formed of a second polymer composition comprising polyethylene. The first and second polymer composition may be the same or different.

Abstract: The present disclosure is related to for disposable wipes. The packages comprise a dispensing fitment and a flexible package body. The packages comprise at least 80% by weight of the total package of one polymer type selected from the group consisting of polyethylene (PE) and polypropylene (PP); and exhibits a recyclability of at least 80% in either the HDPE stream and/or the LDPE stream; or the PP rigids stream and/or the PP flexibles stream.

Abstract: Three-dimensional (3D) image modeling systems and methods are disclosed herein for determining respective mid-section dimensions of individuals. Digital image(s) depicting at least a mid-section portion of an individual are obtained. A fit finder application (app) determines a rough 3D model based on the digital image(s). A parametric 3D model of a predefined individual is mapped to the rough 3D model in virtual 3D space to generate a fitted 3D model indicative of a physical size of at least the mid-section portion of the individual in ordinary space. A mid-section dimension of the individual is then determined based on the fitted 3D model.

Abstract: Three-dimensional (3D) image modeling systems and methods are disclosed herein for determining respective mid-section dimensions of individuals. Digital image(s) depicting at least a mid-section portion of an individual are obtained. A fit finder application (app) determines a rough 3D model based on the digital image(s). A parametric 3D model of a predefined individual is mapped to the rough 3D model in virtual 3D space to generate a fitted 3D model indicative of a physical size of at least the mid-section portion of the individual in ordinary space. A mid-section dimension of the individual is then determined based on the fitted 3D model.

Abstract: A package containing a plurality of disposable absorbent articles, the package being formed of flexible polymeric film, and having a path defining a hood opening structure is disclosed. The hood may be configured so as to serve as an effective package reclosure device whereby the package may be used to store the unused supply of articles following opening.

Abstract: A package containing a plurality of disposable absorbent articles, the package being formed of flexible polymeric film, and having a path defining a hood opening structure is disclosed. The hood may be configured so as to serve as an effective package reclosure device whereby the package may be used to store the unused supply of articles following opening.

Abstract: A package containing a plurality of disposable absorbent articles, the package being formed of flexible polymeric film, and having a path of perforations or scoring defining a hood opening structure is disclosed. The hood may be configured so as to serve as an effective package reclosure device whereby the package may be used to store the unused supply of articles following opening.

Abstract: A package containing a plurality of disposable absorbent articles, the package being formed of flexible polymeric film, and having a path of perforations or scoring defining a hood opening structure is disclosed. The hood may be configured so as to serve as an effective package reclosure device whereby the package may be used to store the unused supply of articles following opening.

Abstract: The invention relates to the use of 2-substituted estra-1,3,5(10)-triene-3-yl sulfamates of general formula I, in addition to their pharmaceutically acceptable salts for producing a medicament. Said compounds have an anti-tumour action.

Abstract: The present invention provides conjugates, processes for their preparation, and the use of these conjugates for transporting low-molecular-weight compounds and macromolecules across biological membranes, in particular for transporting molecules into cells. The present invention also provides pharmaceutical compositions, diagnostic aids, and test kits in which these conjugates are present or used.

Abstract: A process is claimed for making a composite sheet useful as topsheet with one or more openings to receive fecal material useful for an absorbent article, said composite sheet comprising a wrinkled, patterned elasticized region that comprises a patterned first sheet and an elastic material said first sheet being patterned with troughs, that are typically compacter, i.e. of higher density, prior to attachment to the elastic material. The troughs are attached to the elastic material. The resulting composite sheet has a uniform wrinkle pattern. Also claimed are specific absorbent articles. Also claimed are composite sheets with a specific residual strain and peel force value.

Abstract: The present invention relates to the use of 2-alkoxyestrogen sulfamates of general formula I wherein R1 and R2 independently represent H, methyl, C1-C4 acyl, benzoyl R3 represents C1-C4 alkyl or a group of formula CnFmHo, wherein n=1, 2, 3, 4, 5 or 6, m>1, and m+o=2n+1, R4 and R5 in each case represent H or, together, a methylene group or an additional double bond, R6 represents H, R7 represents OH, OC1-C4-alkyl, OC1-C11-acyl or OSO2NR1R2, the dashed lines in the B and C rings of the steroid skeleton additionally representing up to two double bonds, for the production of a medical drug for the treatment of tumor diseases which can be affected positively by inhibiting the tubulin polymerization. The inventive compounds are distinguished by the 2-alkoxy substitution in conjunction with the 17-hydroxy substitution. They have a special effect with regard to inhibiting tubulin polymerization and can be used, for example, for the treatment of prostate cancers.

Abstract: The invention relates to the use of 2-substituted estra-1,3,5(10)-triene-3-yl sulfamates of general formula I, in addition to their pharmaceutically acceptable salts for producing a medicament. Said compounds have an anti-tumour action.

Abstract: A process is claimed for making a composite sheet useful for an absorbent article, the composite sheet comprising a wrinkled, patterned elasticized region that comprises a patterned first sheet and an elastic material, the first sheet being patterned with troughs, that are typically compacter, i.e. of higher density, prior to attachment to the elastic material. The troughs are attached to the elastic material. The resulting composite sheet has a uniform wrinkle pattern. Also claimed are specific absorbent articles.

Abstract: A process is claimed for making a composite sheet useful as topsheet with one or more openings to receive fecal material useful for an absorbent article, said composite sheet comprising a wrinkled, patterned elasticized region that comprises a patterned first sheet and an elastic material said first sheet being patterned with troughs, that are typically compacter, i.e. of higher density, prior to attachment to the elastic material. The troughs are attached to the elastic material. The resulting composite sheet has a uniform wrinkle pattern. Also claimed are specific absorbent articles. Also claimed are composite sheets with a specific residual strain and peel force value.

Abstract: Disclosed are compounds of formula I and use thereof in a method of treating a tumor disease that can be influenced positively by the inhibition of tubulin polymerization.

Abstract: The present invention provides conjugates, processes for their preparation, and the use of these conjugates for transporting low-molecular-weight compounds and macromolecules across biological membranes, in particular for transporting molecules into cells. The present invention also provides pharmaceutical compositions, diagnostic aids, and test kits in which these conjugates are present or used.

Abstract: The present invention provides novel anthracene compounds according to the formulae (I) and (II) and also selected anthracene compound compounds. The present invention furthermore provides a process for preparing such anthracene compounds. Also provided are pharmaceutical formulations comprising these anthracene compounds. The anthracene compounds provided are particularly suitable for the treatment and/or prophylaxis of physiological and/or pathophysiological conditions which can be treated by inhibiting tubulin polymerization and/or by inhibiting microtubuli-based motor proteins, in particular various tumor disorders.

Abstract: This invention relates to 2-substituted D-homo-estra-1,3,5(10)-trien-3-yl sulfamates of general formula I (I), in which R3 means a C1-C5-alkyl or C1-C5-alkyloxy group as well as their use for the production of a pharmaceutical agent for treating tumor diseases, which can be influenced positively by the inhibition of tubulin polymerization. The compounds according to the invention are distinguished by a D-homosubstitution.

Abstract: This invention relates to 2-substituted D-homo-estra-1,3,5(10)-trien-3-yl sulfamates of general formula I (I), in which R3 means a C1-C5-alkyl or C1-C5-alkyloxy group as well as their use for the production of a pharmaceutical agent for treating tumor diseases, which can be influenced positively by the inhibition of tubulin polymerization. The compounds according to the invention are distinguished by a D-homo-substitution.